A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01171313
Recruitment Status : Completed
First Posted : July 28, 2010
Last Update Posted : February 6, 2013
Information provided by (Responsible Party):
XenoPort, Inc.

No Study Results Posted on for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : October 2011
  Actual Study Completion Date : December 2011
  Certification/Extension First Submitted : January 31, 2013